Massachusetts General Hospital, Harvard Medical School is a clinical research site located in Boston, Massachusetts, United States 02114.
Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.
Massachusetts General Hospital, Harvard Medical School has participated in 4 clinical trials.
Therapeutic areas: Hypertension, ICU Acquired Weakness, Follicular Thyroid Cancer.
Sponsors: The Medicines Company, Faraday Pharmaceuticals, Inc., Bhavana Konda.
Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Massachusetts General Hospital, Harvard Medical School has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Massachusetts General Hospital, Harvard Medical School has 4 clinical trials on record. Their work covers Hypertension, ICU Acquired Weakness, Follicular Thyroid Cancer.
Yes — Massachusetts General Hospital, Harvard Medical School holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.